The Customs Rulings Online Search System (CROSS) was updated March 25 with the following headquarters rulings (ruling revocations and modifications will be detailed elsewhere in a separate article as they are announced in the Customs Bulletin):
The Commerce Department and the International Trade Commission published the following Federal Register notices March 22-25 on AD/CVD proceedings:
The Commerce Department and the International Trade Commission published the following Federal Register notices March 21 on AD/CVD proceedings:
The Customs Rulings Online Search System (CROSS) was updated March 19 with the following headquarters rulings (ruling revocations and modifications will be detailed elsewhere in a separate article as they are announced in the Customs Bulletin):
CBP announced an Enforce and Protect Act investigation and said it has reasonable suspicion that Kings Marble and Granite, Musa Stone Import, and KMG Marble and Granite evaded the antidumping and countervailing duty orders on quartz surface products from China. The agency said this finding made the enactment of interim measures necessary.
The Customs Rulings Online Search System (CROSS) was updated March 15-18 with the following headquarters rulings (ruling revocations and modifications will be detailed elsewhere in a separate article as they are announced in the Customs Bulletin):
The Customs Rulings Online Search System (CROSS) was updated March 15 with the following headquarters rulings (ruling revocations and modifications will be detailed elsewhere in a separate article as they are announced in the Customs Bulletin):
CBP is adding an administrative protective order process for companies involved in Enforce and Protect Act investigations to access business confidential information of other "interested parties," so the companies can have full access to CBP's decision-making in a duty evasion investigation, the agency said.
CBP ruled that the fallback method was appropriate for appraising several pharmaceutical products being imported for use in clinical trials. The ruling, dated Feb. 28, looked at three different valuation scenarios, each for pharmaceutical products that were provided to the importer conducting the clinical trial by related companies but were not actually sold.
The Customs Rulings Online Search System (CROSS) was updated March 12 with the following headquarters rulings (ruling revocations and modifications will be detailed elsewhere in a separate article as they are announced in the Customs Bulletin):